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Background
Chlamydia trachomatis is a multifaceted, asymptomatic,
most prevalent sexually transmitted pathogen world-
wide. Due to lack of specific diagnostic methods for
C. trachomatis in Spondyloarthropathy (SpA) patients,
this pathogen is under diagnosed and under estimated in
various countries including India. We aimed to estimate
circulatory antibodies to chlamydial heat shock protein-
60 (chsp60) IgG/ anti C. trachomatis IgA and evaluate
their clinical significance in SpA patients.
Methods
In this case control study, serum from 60 arthritic patients
comprising of Reactive Arthritis (ReA), undifferentiated
SpA, Rheumatoid Arthritis (RA) and Osteoarthritis (OA)
was collected for detection of anti chsp60 IgG and anti
C. trachomatis IgA antibodies by using commercial ELISA
kits. Cut-off indices (COI) of infected SpA patients were
correlated with clinical data.
Results
Overall, 12/ 30 (40.0%) SpA patients, viz.: ReA/uSpA,
were found positive for either circulatory chsp60 IgG or
anti C. trachomatis IgA antibody (p value < 0.009 versus
RA/ OA). 23.3% (7/ 30) SpA patients and 3.3 % (1/30)
RA/OA control patients were found to be positive for cir-
culatory chsp60 IgG antibodies. 16.6% (5/ 30) patients
found positive for anti C. trachomatis IgA antibodies;
however, none of the controls was infected. COI, age and
disease duration in chsp60-positive SpA patients showed
significant difference in median values (Kruskal-Wallis
test; p value < 0.0001) while there was no such relation to
anti C. trachomatis IgA.
Conclusion
Overall findings indicate an active/chronic C. trachomatis
infection in SpA patients. The study also suggests useful-
ness of chsp60 serology to facilitate better clinical manage-
ment of patients.
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